Christine Y. Yee is a Hepatologist based in Ultimo, NSW 2007. Her work focuses on the health of the liver, especially when there are also changes happening in the body’s metabolism. You might see her for problems linked to long-term weight gain, insulin resistance, and health conditions like type 2 diabetes.
In many cases, people come in with non-alcoholic fatty liver disease (NAFLD). This can later turn into non-alcoholic steatohepatitis (NASH), where liver inflammation becomes a bigger issue. Christine also looks after cirrhosis. That means helping patients manage the ongoing effects of long-term liver damage, and working out what the next steps should be based on symptoms and scan or blood results.
Liver health doesn’t sit alone. Obesity can make liver conditions more likely, and it can make them harder to manage over time. Type 2 diabetes can also be part of the bigger picture. Christine’s approach is practical and steady, with an emphasis on understanding what’s driving the liver problem in the first place, not just the test result.
Depending on the situation, her care may also connect with other health needs. The profile lists experience with ovarian cancer, which can matter for people who need careful coordination of treatments when the liver is also involved. At times, liver symptoms and nerve or muscle concerns can overlap with other conditions, including primary lateral sclerosis, so a clear plan and ongoing monitoring are important.
When it comes to how she works with patients, the emphasis is on clear explanations and sorting out what the liver condition could mean for day-to-day life. Treatments and plans can look different from one person to the next, especially when there are multiple conditions involved, like obesity and T2D alongside liver disease.
Education and work history details aren’t listed in this profile, so there’s no specific background information included here. Clinical trials and research details also aren’t provided. What is listed clearly is the focus of her practice across NASH, cirrhosis, NAFLD, obesity-related health, type 2 diabetes, and care where ovarian cancer or primary lateral sclerosis may be part of the wider health story.
